| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/08/2011 | CN102086466A Almond functional hybrid peptide and preparation method thereof |
| 06/08/2011 | CN102086465A Method for preparing polypeptide active substance from enzymolysis ginkgo protein |
| 06/08/2011 | CN102086464A Method for preparing chitin |
| 06/08/2011 | CN102086459A Fusion protein immunosuppressive agent and preparation method and application thereof |
| 06/08/2011 | CN102086455A Flocculation gene of flocculating yeast and expression product and application thereof |
| 06/08/2011 | CN102086452A Bt protein in-vitro insect resistance identification method |
| 06/08/2011 | CN102086440A Method for screening strain producing antifungal proteins and application |
| 06/08/2011 | CN102086231A Fusion protein comprising ubiquitin or ubiquitin-like protein, membrane translocation sequence and biologically active molecule and use thereof |
| 06/08/2011 | CN101591674B Method for producing American cockroach allergen protein Pera 9 in baculovirus-insect expression system |
| 06/08/2011 | CN101570577B Monoclonal antibody for O, O-dimethoxythiophosphate pesticides |
| 06/08/2011 | CN101569690B Preparation method for compound plant polypeptide |
| 06/08/2011 | CN101381727B Construction of human insulinogen C peptide high-yield strains |
| 06/08/2011 | CN101250572B Method for extracting pig blood antibiotic peptide |
| 06/08/2011 | CN101185706B Hippophae rhamnoides nutrition mixture with delaying senility function and preparation technique thereof |
| 06/08/2011 | CN101120085B Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate |
| 06/07/2011 | US7956173 Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate |
| 06/07/2011 | US7955849 Method of enriching a mammalian cell population for mesoderm cells |
| 06/07/2011 | US7955833 Derived from soy hydrolysate and yeast hydrolysate; useful for cultivating cells, such as recombinant cells or cells infected with a virus, and for production biological products by cell culture processes under conditions devoid of animal proteins |
| 06/07/2011 | US7955821 Nucleic acid encoding a self-assembling split-fluorescent protein system |
| 06/07/2011 | US7955807 Method of measuring PTX3 with high sensitivity |
| 06/07/2011 | US7955792 Diluent for norovirus or sapovirus specimen and method for detecting virus |
| 06/07/2011 | US7955599 Cytomegaloviral specific immunoglobulin for use in diagnosis and treatment of cardiovascular disorders |
| 06/07/2011 | US7955597 Anti-IL-6 antibodies, compositions, methods and uses |
| 06/07/2011 | US7955596 B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
| 06/07/2011 | CA2441845C Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 06/07/2011 | CA2438787C Virus derived antimicrobial peptides |
| 06/07/2011 | CA2349838C Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 06/07/2011 | CA2187083C Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/03/2011 | WO2011066501A1 Antibody fc mutants with ablated effector functions |
| 06/03/2011 | WO2011065940A1 Method of supplementing culture media to prevent undesirable amino acid substitutions |
| 06/03/2011 | WO2011064282A1 Method for making polypeptides |
| 06/03/2011 | WO2011063475A1 Methods of preparing hydrogels by enzyme catalysis and subsequent inactivation |
| 06/03/2011 | WO2011011674A3 Production of erythropoiesis stimulating protein using metal ions |
| 06/03/2011 | WO2010129724A3 Efficient biomass fractionating system for an energy pulse crop |
| 06/03/2011 | CA2782218A1 Antibody fc mutants with ablated effector functions |
| 06/02/2011 | US20110131687 Polypeptides having arabinofuranosidase activity and polynucleotides encoding same |
| 06/02/2011 | US20110131670 Non-Aggregating Fluorescent Proteins and Methods for Using the Same |
| 06/02/2011 | US20110130544 Antibodies with decreased deamidation profiles |
| 06/02/2011 | US20110130329 Glp-1 Fusion Peptides, Their Production and Use |
| 06/02/2011 | US20110130319 Subtilases |
| 06/02/2011 | US20110129878 Bioreactive agents |
| 06/02/2011 | US20110129876 Constructs and Methods for the Production and Secretion of Polypeptides |
| 06/02/2011 | US20110129875 Immunosupprressive polypeptides and nucleic acids |
| 06/02/2011 | US20110129874 Pichia Pastoris Das Promoter Variants |
| 06/02/2011 | US20110129873 Recombinant DNA Vectors for Expression of Human Prolactin Antagonists |
| 06/02/2011 | US20110129872 Method for a production of a recombinant protein using yeast co-expression system |
| 06/02/2011 | US20110129855 Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions |
| 06/02/2011 | US20110129487 Plasmic production and expression of recombinant proteins in cells grown without antibiotics |
| 06/02/2011 | US20110129480 Anti-ferroportin 1 monoclonal antibodies and uses thereof |
| 06/02/2011 | US20110129477 NOGO Receptor Homologs |
| 06/02/2011 | US20110129476 Mzb1, a novel b cell factor, and uses thereof |
| 06/02/2011 | US20110129475 Basb 205 polypeptides and polynucleotides from haemophilus influenzae |
| 06/02/2011 | US20110129464 Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies |
| 06/02/2011 | US20110129458 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof |
| 06/02/2011 | US20110129457 Variant hhip1 protein and methods and uses thereof |
| 06/02/2011 | US20110129414 Single Chain Fragment of Monoclonal Antibody 9B9 and Uses Thereof |
| 06/01/2011 | EP2327985A2 T1R Hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 06/01/2011 | EP2327778A1 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and use of the same |
| 06/01/2011 | EP2327724A2 Modified human growth hormone polypeptides and their uses |
| 06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 06/01/2011 | EP2326716A1 Enhanced animal cell growth using ultrasound |
| 06/01/2011 | EP2326347A2 Targeting pathogenic monocytes |
| 06/01/2011 | EP1354946B1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 06/01/2011 | CN102084249A Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 06/01/2011 | CN102083984A Cynomolgus toll-like receptor 3 |
| 06/01/2011 | CN102080118A Preparation method of rice bran antioxidant active protein peptide |
| 06/01/2011 | CN102080117A Inflammatory factor receptor antagonist of microbial source and preparation method thereof |
| 06/01/2011 | CN102080107A Method for synchronously preparing walnut oil and walnut protein peptide by microwave-assisted protease hydrolysis |
| 06/01/2011 | CN102080101A Targeted exogenous gene integration method |
| 06/01/2011 | CN102080098A Eukaryon expression vector and application thereof to preparing medicament for inhibiting leukemia cell proliferation |
| 06/01/2011 | CN102080095A Eukaryotic expression vector containing mature peptide gene of epinephelus coioids gonadotropin hormone I, recombinant strain, recombinant protein and application thereof |
| 06/01/2011 | CN102080073A Method for producing derived factor -1(SDF-1) of human stroma cells on a large scale by using mammal cells |
| 06/01/2011 | CN102080064A TGase-activating protease inhibitor producing engineering bacteria and construction method thereof |
| 06/01/2011 | CN102080056A New enramycin-producing strain and high-yielding mutant strain thereof |
| 06/01/2011 | CN102079785A Thymopoietin-II mutant |
| 06/01/2011 | CN102079784A Canine interferon-Alpha mutant |
| 06/01/2011 | CN102079778A Antibacterial protein and preparation method and application thereof |
| 06/01/2011 | CN102078613A Inhibitors of her3 activity |
| 06/01/2011 | CN102078335A Preparation method of latic acid hirudo liquid |
| 06/01/2011 | CN101640085B Preparation of fibrin magnetic micrometer material for separating mRNA and application thereof |
| 06/01/2011 | CN101440390B Method for preparing vegetable seed active peptide by mixed bacteria solid-state fermentation |
| 06/01/2011 | CN101240313B Method for preparing scale collagen peptide |
| 06/01/2011 | CN101100681B Stemmacantha uniflora enzymolysis liquid and its preparing process and application |
| 05/31/2011 | US7951928 Comprising amino acid sequences 1 to 3 derivatives having negative effect on transcriptional activation factor YAP (Yes Associated Protein); encoding genes, recombinant vectors, transformants; neurodegenerative diseases |
| 05/31/2011 | US7951923 Fluorescent proteins and chromoproteins from non-Aequorea hydrozoa species and methods for using same |
| 05/31/2011 | US7951920 Conjugate of an antibody against CCR5 and an antifusogenic peptide |
| 05/31/2011 | US7951919 TACI-immunoglobulin fusion proteins |
| 05/31/2011 | US7951918 Stabilized polypeptide compositions |
| 05/31/2011 | US7951917 Method for making multispecific antibodies having heteromultimeric and common components |
| 05/31/2011 | US7951916 Il-1 related polypeptides |
| 05/31/2011 | US7951914 Genetically modified cyclic-nucleotide controlled ion channels |
| 05/31/2011 | US7951912 Poly-β-peptides from functionalized β-lactam monomers and antibacterial compositions containing same |
| 05/31/2011 | US7951909 A polypeptide containing an N-terminal fragment of Amyloid beta (A beta ) peptide linked to a helper T cell epitope (Th) having multiple class II binding motifs; generated antibodies are highly cross-reactive to the soluble A beta 1-42 peptide and the amyloid plaques in the brain |
| 05/31/2011 | US7951589 Monoclonal antibodies specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 05/31/2011 | US7951570 CBH1 homologs and variant CBH1 cellulases |
| 05/31/2011 | US7951561 Method for the preparation of κ-carrageenase |
| 05/31/2011 | US7951560 Delta 4,5 glycuronidase compositions and methods related thereto |
| 05/31/2011 | US7951559 Recombinant peptide production using a cross-linkable solubility tag |
| 05/31/2011 | US7951558 microorganism co-transformed with a recombinant expression vector containing E. coli outer membrane protein F (OmpF) and a recombinant expression vector containing a target protein to be secreted into cell culture broth, as well as a method of secreting and producing the target protein into cell culture |
| 05/31/2011 | US7951557 Human lysosomal proteins from plant cell culture |